Drugs / Melan-A EAA
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00112242 | Feb 2004 → Mar 2013 | melanoma | Centre Hospitalier Universitaire Vaudois | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Melan-A EAA | “100 mcg Melan-A EAA native peptide (during first cycle)” NCT00112242 ↗ |
| Modality | Peptide | “100 mcg Melan-A EAA native peptide” NCT00112242 ↗ |